267 related articles for article (PubMed ID: 35955408)
1. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3.
Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the Molecular Details of the Interactions of Selenoglycosides and Human Galectin-3.
Raics M; Balogh ÁK; Kishor C; Timári I; Medrano FJ; Romero A; Go RM; Blanchard H; Szilágyi L; E Kövér K; Fehér K
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269646
[TBL] [Abstract][Full Text] [Related]
3. Thermodynamic binding studies of galectin-1, -3 and -7.
Brewer CF
Glycoconj J; 2002; 19(7-9):459-65. PubMed ID: 14758069
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
[TBL] [Abstract][Full Text] [Related]
5. Human galectin-1 and galectin-3 promote
Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
[No Abstract] [Full Text] [Related]
6. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors.
Etulain J; Negrotto S; Tribulatti MV; Croci DO; Carabelli J; Campetella O; Rabinovich GA; Schattner M
PLoS One; 2014; 9(4):e96402. PubMed ID: 24788652
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Anticancer Activity of a Selenium-Containing Galectin-3 and Galectin-9N Inhibitor.
Di Gaetano S; Pirone L; Galdadas I; Traboni S; Iadonisi A; Pedone E; Saviano M; Gervasio FL; Capasso D
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269724
[TBL] [Abstract][Full Text] [Related]
8. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
9. Lactulose as a novel template for anticancer drug development targeting galectins.
Kishor C; Ross RL; Blanchard H
Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
[TBL] [Abstract][Full Text] [Related]
10. Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells.
Obermann J; Priglinger CS; Merl-Pham J; Geerlof A; Priglinger S; Götz M; Hauck SM
Mol Cell Proteomics; 2017 Aug; 16(8):1528-1546. PubMed ID: 28576849
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for distinct binding properties of the human galectins to Thomsen-Friedenreich antigen.
Bian CF; Zhang Y; Sun H; Li DF; Wang DC
PLoS One; 2011; 6(9):e25007. PubMed ID: 21949831
[TBL] [Abstract][Full Text] [Related]
12. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications.
Nowowiejska J; Baran A; Hermanowicz JM; Sieklucka B; Pawlak D; Flisiak I
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892153
[TBL] [Abstract][Full Text] [Related]
14. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc.
Hsieh TJ; Lin HY; Tu Z; Huang BS; Wu SC; Lin CH
PLoS One; 2015; 10(5):e0125946. PubMed ID: 25945972
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
[TBL] [Abstract][Full Text] [Related]
17. High-Affinity
Tavares MR; Bláhová M; Sedláková L; Elling L; Pelantová H; Konefał R; Etrych T; Křen V; Bojarová P; Chytil P
Biomacromolecules; 2020 Feb; 21(2):641-652. PubMed ID: 31904940
[No Abstract] [Full Text] [Related]
18. Targeting the CRD F-face of Human Galectin-3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative.
Miller MC; Zheng Y; Suylen D; Ippel H; Cañada FJ; Berbís MA; Jiménez-Barbero J; Tai G; Gabius HJ; Mayo KH
ChemMedChem; 2021 Feb; 16(4):713-723. PubMed ID: 33156953
[TBL] [Abstract][Full Text] [Related]
19. Investigations on the binding specificity of β-galactoside analogues with human galectin-1 using molecular dynamics simulations.
Jino Blessy J; Siva Shanmugam NR; Veluraja K; Michael Gromiha M
J Biomol Struct Dyn; 2022; 40(20):10094-10105. PubMed ID: 34219624
[TBL] [Abstract][Full Text] [Related]
20. Galectin-Glycan Interactions: Guidelines for Monitoring by
Diercks T; Medrano FJ; FitzGerald FG; Beckwith D; Pedersen MJ; Reihill M; Ludwig AK; Romero A; Oscarson S; Cudic M; Gabius HJ
Chemistry; 2021 Jan; 27(1):316-325. PubMed ID: 32955737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
